NCT02383628|Completed
Endoscopic Perfusion Utilizing ICG Fluorescence Technology
ICG
Loading search results
ICG
Sponsor study identifier
observational
197
1 country
1
Study Start
October 2015
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2018
Actual (reported)Study Completion
June 2018
Actual (reported)The main objective of the study is to evaluate the efficacy of indocyanine green (ICG) endoscopy to evaluate tissue perfusion during endoscopic neurosurgery. This includes patients with pituitary and intracranial tumors and treatment of vascular abnormalities such as aneurysms and compressive syndromes. ICG will be evaluated to determine the value of the additional visual information supplied during the treatment of these pathologies.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2018
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 3, 2015
Actual (reported)March 9, 2015
Actual (reported)October 2015
Date type not reportedThis date has not been verified as actual or estimated.
June 2018
Actual (reported)June 2018
Actual (reported)Efficacy as measured by observation
compare efficacy of tissue perfusion with and without ICG Dye and light filter
up to 52 weeks
Patient population would include those patients with pituitary tumors, intracranial tumors, aneurysms, and normal tissue adjacent to tumors to clarify normal from abnormal. Also, patients with compressive syndromes to ensure patency of normal vessels. This would be all patients undergoing endoscopic surgery, both endonasal and open (retromastoid or transcranial).
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
Paul Gardner, MD
University of Pittsburgh Medical Center
197 participants (actual enrollment reported by the registry).
First Submitted
March 3, 2015
First Posted
March 9, 2015
Study Start
October 2015
Date type not reportedThis date has not been verified as actual or estimated.
Use of Personal Fitness Device in Adult (> 21 Years Old) Patients With Cystic Fibrosis
Contact the study team to confirm eligibility.
Primary Completion
June 2018
Actual (reported)Study Completion
June 2018
Actual (reported)Last Updated
July 5, 2018
Record last verified: 2018-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: